GenomOncology

About:

GenomOncology enables precision medicine by translating next generation sequencing data into actionable information.

Website: http://www.genomoncology.com

Top Investors: JumpStart, North Coast Ventures, Zapis Capital Group, TriStar Health Partners

Description:

A venture backed and Cleveland, OH based healthcare technology company, GenomOncology is enabling precision medicine by transforming data into actionable information. We offer the GO Precision Medicine Portfolio - a suite of solutions that addresses the full range of needs for Healthcare Institutions. The portfolio supports technical assay validation and testing, clinical decision support, collaborative decision support for Molecular Tumor Board workflows and analytics for monitoring and discovery – to enable cancer precision medicine.

Total Funding Amount:

$2.89M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cleveland, Ohio, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)genomoncology.com

Founders:

Manuel Glynias

Number of Employees:

11-50

Last Funding Date:

2019-11-22

IPO Status:

Private

Industries: